Sign Up to like & get recommendations! 0
Published in 2024 at "Cancer"
DOI: 10.1002/cncr.35660
Abstract: Retroperitoneal sarcoma is a complex entity that requires specialized surgical management. Three‐dimensional printing technology may represent a valuable adjunctive tool for the preoperative assessment and surgical planning of retroperitoneal sarcoma. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24557
Abstract: We sought to examine our outcomes with advanced preoperative and intraoperative radiation therapy (XRT) combined with aggressive en bloc surgical resection of retroperitoneal sarcoma (RPS) as a strategy to minimize the risk of local recurrence… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24710
Abstract: The volume‐outcome relationship is well recognized. We sought to investigate this relationship in retroperitoneal sarcoma (RPS) surgery. read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.70074
Abstract: Retroperitoneal sarcoma (RPS) is a rare cancer, so few reports have previously characterized its national profiles. The capture rate of RPS in the Bone and Soft Tissue Tumor Registry was only 20%. The present study… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "American journal of surgery"
DOI: 10.1016/j.amjsurg.2020.11.011
Abstract: BACKGROUND Prior studies evaluating the impact of adjuvant or neoadjuvant radiation on clinical outcomes of patients with non-lipomatous retroperitoneal sarcoma have been underpowered. METHODS We queried the National Cancer Database to identify patients undergoing surgical… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Surgery"
DOI: 10.1016/j.surg.2017.07.009
Abstract: Background Operative resection remains the definitive curative therapy for retroperitoneal sarcoma. Data published recently show a correlation between improved outcomes for complex oncologic operations and treatment at academic centers. For large retroperitoneal sarcomas, operative resection… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Journal of cardiothoracic and vascular anesthesia"
DOI: 10.1053/j.jvca.2023.03.009
Abstract: OBJECTIVE To describe the introduction of extracorporeal corporeal oxygenation (ECMO) to facilitate the surgical resection of large retroperitoneal sarcomas involving major vessels and to report preliminary outcomes. DESIGN A case series. SETTING At a tertiary… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "BJS Open"
DOI: 10.1093/bjsopen/zrab080
Abstract: Abstract Background The prognostic significance of histological organ involvement by retroperitoneal sarcoma subtype is unknown. The present study aimed to describe organ involvement across the subtypes, and the implications for survival. Methods Patients undergoing surgery… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Radiation Research"
DOI: 10.1093/jrr/rrac002
Abstract: Abstract From August 2019 to August 2020, we inserted polyglycolic acid (PGA) spacers and administered carbon ion radiotherapy (CIRT) to three cases of retroperitoneal sarcoma at our hospital. We aimed to investigate its utility and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Annals of surgery"
DOI: 10.1097/sla.0000000000005625
Abstract: OBJECTIVE The Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) conducted a retrospective study on the disease course and clinical management of ganglioneuromas. BACKGROUND Ganglioneuromas are rare tumors derived from neural crest cells. Data on these… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "International Journal of Urology"
DOI: 10.1111/iju.70069
Abstract: To evaluate the prognostic impact of intratumoral tertiary lymphoid structures (TLSs) in patients with retroperitoneal sarcoma undergoing primary curative surgery, focusing on their relationship with immune microenvironment components and survival outcomes. read more here.